Baxter International (BAX) Debt/Assets Ratio: History & Chart

Baxter International Inc. (BAX)BAXBaxter International Inc.

About Baxter International Inc.

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.

Deerfield, IL

37,500 employees

www.baxter.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Andrew Hider

View full financials

BAX Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

48.81%

DEBT TO ASSETS RATIO AVG TTM

47.66%

DEBT TO ASSETS RATIO AVG 3Y

49.70%

DEBT TO ASSETS RATIO AVG 5Y

52.83%

DEBT TO ASSETS RATIO AVG 10Y

37.95%

DEBT TO ASSETS RATIO AVG 15Y

36.15%

DEBT TO ASSETS RATIO AVG 20Y

32.75%

CURRENT VS TTM AVG

+2.43%

CURRENT VS 3Y AVG

-1.80%

CURRENT VS 5Y AVG

-7.60%

CURRENT VS 10Y AVG

+28.62%

CURRENT VS 15Y AVG

+35.03%

CURRENT VS 20Y AVG

+49.05%

SECTOR MEDIAN · HEALTHCARE

0.29%

median of 79 covered companies

CURRENT VS SECTOR MEDIAN

+16731.33%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Baxter International Inc. (BAX)	$11.57B	48.81%	47.66%	49.70%	52.83%
Insulet Corp. (PODD)vs ›	$11.31B	0.33%	N/A	N/A	N/A
Bio-Techne Corporation (TECH)vs ›	$11.21B	0.17%	N/A	N/A	N/A
Align Technology, Inc. (ALGN)vs ›	$11.96B	0.02%	N/A	N/A	N/A
Charles River Laboratories International, Inc. (CRL)vs ›	$10.91B	0.43%	N/A	N/A	N/A
Revvity, Inc. (RVTY)vs ›	$12.32B	0.29%	N/A	N/A	N/A
Walgreens Boots Alliance, Inc. (WBA)vs ›	$10.37B	0.42%	N/A	N/A	N/A
Molina Healthcare, Inc. (MOH)vs ›	$10.31B	0.25%	N/A	N/A	N/A
Universal Health Services, Inc. (UHS)vs ›	$9.75B	0.35%	N/A	N/A	N/A
Henry Schein, Inc. (HSIC)vs ›	$9.74B	0.33%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Baxter International Inc. (BAX)

$11.57B

48.81%

47.66%

49.70%

52.83%

Insulet Corp. (PODD)vs ›

$11.31B

0.33%

N/A

Bio-Techne Corporation (TECH)vs ›

$11.21B

0.17%

N/A

Align Technology, Inc. (ALGN)vs ›

$11.96B

0.02%

N/A

Charles River Laboratories International, Inc. (CRL)vs ›

$10.91B

0.43%

N/A

Revvity, Inc. (RVTY)vs ›

$12.32B

0.29%

N/A

Walgreens Boots Alliance, Inc. (WBA)vs ›

$10.37B

0.42%

N/A

Molina Healthcare, Inc. (MOH)vs ›

$10.31B

0.25%

N/A

Universal Health Services, Inc. (UHS)vs ›

$9.75B

0.35%

N/A

Henry Schein, Inc. (HSIC)vs ›

$9.74B

0.33%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Baxter International Inc. (BAX)?

The debt to assets ratio for BAX stock is 48.81%.

Is Baxter International Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 48.81% is in line with its 5-year average of 50.04%, around the middle of its 5-year range (32.51%–60.82%).

What is the TTM average debt to assets ratio for Baxter International Inc. (BAX)?

The TTM average debt to assets ratio for BAX stock is 47.66%.

What is the 3Y average debt to assets ratio for Baxter International Inc. (BAX)?

The 3Y average debt to assets ratio for BAX stock is 49.70%.

What is the 5Y average debt to assets ratio for Baxter International Inc. (BAX)?

The 5Y average debt to assets ratio for BAX stock is 52.83%.

What is the 10Y average debt to assets ratio for Baxter International Inc. (BAX)?

The 10Y average debt to assets ratio for BAX stock is 37.95%.

What is the 15Y average debt to assets ratio for Baxter International Inc. (BAX)?

The 15Y average debt to assets ratio for BAX stock is 36.15%.

What is the 20Y average debt to assets ratio for Baxter International Inc. (BAX)?

The 20Y average debt to assets ratio for BAX stock is 32.75%.

DATE	DEBT TO ASSETS RATIO
2026-03-31	48.81%
2025-12-31	48.77%
2025-09-30	46.10%
2025-06-30	46.21%
2025-03-31	48.39%
2024-12-31	52.16%
2024-09-30	49.46%
2024-06-30	50.71%
2024-03-31	50.99%
2023-12-31	49.91%
2023-09-30	55.22%
2023-06-30	60.68%
2023-03-31	59.70%
2022-12-31	60.82%
2022-09-30	60.38%
2022-06-30	53.90%
2022-03-31	54.05%
2021-12-31	54.62%
2021-09-30	32.51%
2021-06-30	33.72%
2021-03-31	33.70%
2020-12-31	33.99%
2020-09-30	34.71%
2020-06-30	35.25%
2020-03-31	36.79%
2019-12-31	32.77%
2019-09-30	32.13%
2019-06-30	32.21%
2019-03-31	28.56%
2018-12-31	22.17%
2018-09-30	20.70%
2018-06-30	21.10%
2018-03-31	21.04%
2017-12-31	20.52%
2017-09-30	19.94%
2017-06-30	20.38%
2017-03-31	17.80%
2016-12-31	17.90%
2016-09-30	17.98%
2016-06-30	19.82%
2016-03-31	19.35%
2015-12-31	31.04%
2015-09-30	33.36%
2015-06-30	47.37%
2015-03-31	40.24%
2014-12-31	34.54%
2014-09-30	36.26%
2014-06-30	34.49%
2014-03-31	34.42%
2013-12-31	36.34%
2013-09-30	35.90%
2013-06-30	38.04%
2013-03-31	28.88%
2012-12-31	29.08%
2012-09-30	30.00%
2012-06-30	28.81%
2012-03-31	27.73%
2011-12-31	27.24%
2011-09-30	25.46%
2011-06-30	24.80%
2011-03-31	25.12%
2010-12-31	25.08%
2010-09-30	27.80%
2010-06-30	29.20%
2010-03-31	27.69%
2009-12-31	23.92%
2009-09-30	24.59%
2009-06-30	24.34%
2009-03-31	26.15%
2008-12-31	24.38%
2008-09-30	22.49%
2008-06-30	20.90%
2008-03-31	19.18%
2007-12-31	20.20%
2007-09-30	18.17%
2007-06-30	18.53%
2007-03-31	18.78%
2006-12-31	19.07%
2006-09-30	20.16%
2006-06-30	18.14%
2006-03-31	18.82%
2005-12-31	26.23%
2005-09-30	31.65%
2005-06-30	32.94%
2005-03-31	33.31%
2004-12-31	30.35%
2004-09-30	33.33%
2004-06-30	33.92%
2004-03-31	35.01%
2003-12-31	33.37%
2003-09-30	36.91%
2003-06-30	37.51%
2003-03-31	42.67%
2002-12-31	37.24%
2002-09-30	28.09%
2002-06-30	31.35%

DATE

DEBT TO ASSETS RATIO

2026-03-31

48.81%

2025-12-31

48.77%

2025-09-30

46.10%

2025-06-30

46.21%

2025-03-31

48.39%

2024-12-31

52.16%

2024-09-30

49.46%

2024-06-30

50.71%

2024-03-31

50.99%

2023-12-31

49.91%

2023-09-30

55.22%

2023-06-30

60.68%

2023-03-31

59.70%

2022-12-31

60.82%

2022-09-30

60.38%

2022-06-30

53.90%

2022-03-31

54.05%

2021-12-31

54.62%

2021-09-30

32.51%

2021-06-30

33.72%

2021-03-31

33.70%

2020-12-31

33.99%

2020-09-30

34.71%

2020-06-30

35.25%

2020-03-31

36.79%

2019-12-31

32.77%

2019-09-30

32.13%

2019-06-30

32.21%

2019-03-31

28.56%

2018-12-31

22.17%

2018-09-30

20.70%

2018-06-30

21.10%

2018-03-31

21.04%

2017-12-31

20.52%

2017-09-30

19.94%

2017-06-30

20.38%

2017-03-31

17.80%

2016-12-31

17.90%

2016-09-30

17.98%

2016-06-30

19.82%

2016-03-31

19.35%

2015-12-31

31.04%

2015-09-30

33.36%

2015-06-30

47.37%

2015-03-31

40.24%

2014-12-31

34.54%

2014-09-30

36.26%

2014-06-30

34.49%

2014-03-31

34.42%

2013-12-31

36.34%

2013-09-30

35.90%

2013-06-30

38.04%

2013-03-31

28.88%

2012-12-31

29.08%

2012-09-30

30.00%

2012-06-30

28.81%

2012-03-31

27.73%

2011-12-31

27.24%

2011-09-30

25.46%

2011-06-30

24.80%

2011-03-31

25.12%

2010-12-31

25.08%

2010-09-30

27.80%

2010-06-30

29.20%

2010-03-31

27.69%

2009-12-31

23.92%

2009-09-30

24.59%

2009-06-30

24.34%

2009-03-31

26.15%

2008-12-31

24.38%

2008-09-30

22.49%

2008-06-30

20.90%

2008-03-31

19.18%

2007-12-31

20.20%

2007-09-30

18.17%

2007-06-30

18.53%

2007-03-31

18.78%

2006-12-31

19.07%

2006-09-30

20.16%

2006-06-30

18.14%

2006-03-31

18.82%

2005-12-31

26.23%

2005-09-30

31.65%

2005-06-30

32.94%

2005-03-31

33.31%

2004-12-31

30.35%

2004-09-30

33.33%

2004-06-30

33.92%

2004-03-31

35.01%

2003-12-31

33.37%

2003-09-30

36.91%

2003-06-30

37.51%

2003-03-31

42.67%

2002-12-31

37.24%

2002-09-30

28.09%

2002-06-30

31.35%

Debt to Assets Ratio: 48.81%

BAX Debt to Assets Ratio

BAX Average Debt to Assets Ratio Chart

BAX Current vs Average Debt to Assets Ratio Chart

BAX Debt to Assets Ratio Metrics

BAX Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

BAX Debt to Assets Ratio History

Related Metrics